IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 3473 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

REVIEW ARTICLE

Promising molecular targeted therapies in breast cancer

Munagala Radha, Aqil Farrukh, Gupta Ramesh C

Year : 2011| Volume: 43| Issue : 3 | Page no: 236-245

   This article has been cited by
 
1 Identification and validation of a prognostic risk model based on caveolin family genes for breast cancer
Qiang Tang, Shurui Wang, Ziyang Di, Huimin Li, Kailiang Xu, Xin Hu, Maojun Di
Frontiers in Cell and Developmental Biology. 2022; 10
[Pubmed]  [Google Scholar] [DOI]
2 YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development
Miwa Fujihara, Tadahiko Shien, Kazuhiko Shien, Ken Suzawa, Tatsuaki Takeda, Yidan Zhu, Tomoka Mamori, Yusuke Otani, Ryo Yoshioka, Maya Uno, Yoko Suzuki, Yuko Abe, Minami Hatono, Takahiro Tsukioki, Yuko Takahashi, Mariko Kochi, Takayuki Iwamoto, Naruto Taira, Hiroyoshi Doihara, Shinichi Toyooka
International Journal of Molecular Sciences. 2021; 22(23): 12809
[Pubmed]  [Google Scholar] [DOI]
3 Exosomal-mediated transfer of OIP5-AS1 enhanced cell chemoresistance to trastuzumab in breast cancer via up-regulating HMGB3 by sponging miR-381-3p
Qiang Yu, Yinmou Li, Shijun Peng, Jing Li, Xianxiong Qin
Open Medicine. 2021; 16(1): 512
[Pubmed]  [Google Scholar] [DOI]
4 Immunotherapy for Breast Cancer Treatment
Miganoosh Simonian, Mozhan Haji Ghaffari, Babak Negahdari
Iranian Biomedical Journal. 2021; 25(3): 140
[Pubmed]  [Google Scholar] [DOI]
5 Role of miRNAs in regulating responses to radiotherapy in human breast cancer
Zhi Xiong Chong, Swee Keong Yeap, Wan Yong Ho
International Journal of Radiation Biology. 2021; 97(3): 289
[Pubmed]  [Google Scholar] [DOI]
6 Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach
Balak Das Kurmi, Rishi Paliwal, Shivani Rai Paliwal
International Journal of Biological Macromolecules. 2020; 164: 2881
[Pubmed]  [Google Scholar] [DOI]
7 Breast Cancer Targeted Treatment Strategies: Promising Nanocarrier Approaches
Sivakumar P. Malliappan, Palanivel Kandasamy, Siva Chidambaram, Devanand Venkatasubbu, Sathish K. Perumal, Abimanyu Sugumaran
Anti-Cancer Agents in Medicinal Chemistry. 2020; 20(11): 1300
[Pubmed]  [Google Scholar] [DOI]
8 Experimental Models as Refined Translational Tools for Breast Cancer Research
Eduardo Costa, Tânia Ferreira-Gonçalves, Gonçalo Chasqueira, António S. Cabrita, Isabel V. Figueiredo, Catarina Pinto Reis
Scientia Pharmaceutica. 2020; 88(3): 32
[Pubmed]  [Google Scholar] [DOI]
9 Transcriptional activation of EGFR by HOXB5 and its role in breast cancer cell invasion
Ji-Yeon Lee, Jie Min Kim, Da Som Jeong, Myoung Hee Kim
Biochemical and Biophysical Research Communications. 2018; 503(4): 2924
[Pubmed]  [Google Scholar] [DOI]
10 Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer
Eden R. Padayachee, Fleury Augustin Nsole Biteghe, Zaria Malindi, Dirk Bauerschlag, Stefan Barth
Transfusion Medicine and Hemotherapy. 2017; 44(5): 303
[Pubmed]  [Google Scholar] [DOI]
11 Anticancer activity of an ultrasonic nanoemulsion formulation of Nigella sativa L. essential oil on human breast cancer cells
Vaiyapuri Subbarayan Periasamy, Jegan Athinarayanan, Ali A. Alshatwi
Ultrasonics Sonochemistry. 2016; 31: 449
[Pubmed]  [Google Scholar] [DOI]
12 Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer
Anusha Sebastian, Vijay Pandey, Chakrabhavi Dhananjaya Mohan, Yi Ting Chia, Shobith Rangappa, Jessin Mathai, C. P. Baburajeev, Shardul Paricharak, Lewis H. Mervin, Krishna C. Bulusu, Julian E. Fuchs, Andreas Bender, Shuhei Yamada, Basappa, Peter E. Lobie, Kanchugarakoppal S. Rangappa
ACS Omega. 2016; 1(6): 1412
[Pubmed]  [Google Scholar] [DOI]
13 Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case–control study
Jalila Rahoui,Abdelilah Laraqui,Yassir Sbitti,Nadia Touil,Azeddine Ibrahimi,Brahim Ghrab,Abderrahman Al Bouzidi,Driss Moussaoui Rahali,Mohamed Dehayni,Mohamed Ichou,Fatima Zaoui,Saad Mrani
Medical Oncology. 2014; 31(9)
[Pubmed]  [Google Scholar] [DOI]
14 Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin ß1
Yinying Dong,Xiaoying Xie,Zhiming Wang,Chao Hu,Qiongdan Zheng,Yaohui Wang,Rongxin Chen,Tongchun Xue,Jie Chen,Dongmei Gao,Weizhong Wu,Zhenggang Ren,Jiefeng Cui
Biochemical and Biophysical Research Communications. 2014;
[Pubmed]  [Google Scholar] [DOI]
15 IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors
Holly A. Porter,Anthony Perry,Chris Kingsley,Nhan L. Tran,Achsah D. Keegan
Cancer Letters. 2013; 338(2): 239
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow